Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Newborn Screening topic
No spam. Unsubscribe anytime.
Nevada newborn‑screening modernization pitched as life‑saving, fee increase proposed
Summary
Sponsor and patient advocates told the Senate HHS committee SB348 would align Nevada with the federal Recommended Uniform Screening Panel, expand lab capacity and add genetic‑counselor licensure; sponsors proposed raising the newborn‑screening fee to sustain the program.
CARSON CITY — Supporters of Senate Bill 348 told the Senate Committee on Health and Human Services that modernizing Nevada’s newborn‑screening program could identify life‑threatening but treatable conditions earlier, reduce long‑term costs and expand in‑state genetic services.
Sponsor and testimony: Senator Julie Pizzina (SD 12) presented the bill on behalf of its author. Annette Logan Parker, founder of the Cure for the Kids Foundation and chair of the Nevada Rare Disease Advisory Council, said the measure would do four things: automatically adopt all federally recommended RUSP conditions, update the newborn‑screening fee with modest inflation adjustments, strengthen follow‑up care and authorize licensure of genetic counselors to expand in‑state access.
Why it matters: Supporters said expanded screening can prevent irreversible damage and reduce future spending on emergency and long‑term care. Several parents and clinicians described cases in which delayed diagnosis resulted in severe, avoidable harms.
Key testimony and details
- Annette Logan Parker (Cure for the Kids Foundation) said SB348 "isn't about starting something new; it's about bringing Nevada in line with national standards," and described an increase in the newborn‑screening fee from an historical low to a proposed higher rate that would be embedded in hospital reimbursement rather than billed directly to families.
- Dr. Sumit Gupta, chair of the Nevada Newborn Screening Advisory Council, described public‑health benefits of early detection and noted Nevada previously lagged in adopting conditions such as cystic fibrosis and spinal muscular atrophy.
- Stephanie Vanhoozer, administrative director of the Nevada State Public Health Laboratory, said Nevada's lab began in‑state newborn screening in 2014 and still lacks five core RUSP conditions; she said a sustainable, modernized fee model is essential to expand testing capacity and maintain rapid turnaround.
- Parents and advocates testified with personal accounts: a mother of a child with infantile‑onset Pompe disease described lengthy out‑of‑state diagnosis and treatment; a father who lost a son to a rare cancer said delays in tumor genetic testing contributed to treatment delays.
Questions and clarifications
- Senator Titus pressed on whether the bill actually increases the number of tests required; Logan Parker confirmed SB348 would align Nevada's panel with the federally recommended panel and that the state public health lab would need equipment and capacity investments.
- Committee staff and public‑health witnesses confirmed the screening fee has not been updated in more than a decade; testimony said the proposed increase would generally be embedded in hospital labor‑and‑delivery reimbursement and not billed separately to families, though hospitals would carry the reimbursement differences.
- Logan Parker and the Nevada State Public Health Laboratory said the fee remains among the lowest nationally even after the proposed change, and that federal funds (HRSA) previously supported earlier expansions.
Status and next steps: SB348 received extensive support testimony during the hearing; committee members asked clarifying questions. No committee vote on final passage was recorded in this hearing record; the bill will proceed through the committee process where amendments and fiscal detail may be added.
Provenance
- Topic intro evidence: block_86 ("I'm gonna open the bill hearing on Senate Bill 3 48. This bill revises provisions relating to health care...") - Topic finish evidence: block_153 (close of support testimony and end of hearing for SB348)
